DK1027361T3 - Derivater af erythromycin med 6,11-bro - Google Patents

Derivater af erythromycin med 6,11-bro

Info

Publication number
DK1027361T3
DK1027361T3 DK98956314T DK98956314T DK1027361T3 DK 1027361 T3 DK1027361 T3 DK 1027361T3 DK 98956314 T DK98956314 T DK 98956314T DK 98956314 T DK98956314 T DK 98956314T DK 1027361 T3 DK1027361 T3 DK 1027361T3
Authority
DK
Denmark
Prior art keywords
erythromycin
bridge
derivatives
Prior art date
Application number
DK98956314T
Other languages
English (en)
Inventor
Yat Sun Or
George Griesgraber
Daniel T Chu
Leping Li
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1027361T3 publication Critical patent/DK1027361T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK98956314T 1997-10-29 1998-10-29 Derivater af erythromycin med 6,11-bro DK1027361T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
DK1027361T3 true DK1027361T3 (da) 2003-08-25

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956314T DK1027361T3 (da) 1997-10-29 1998-10-29 Derivater af erythromycin med 6,11-bro

Country Status (23)

Country Link
EP (1) EP1027361B1 (da)
JP (1) JP2001521038A (da)
KR (1) KR20010031591A (da)
CN (1) CN1278266A (da)
AR (1) AR015986A1 (da)
AT (1) ATE239750T1 (da)
AU (1) AU1286799A (da)
BG (1) BG104425A (da)
BR (1) BR9813317A (da)
CA (1) CA2307828A1 (da)
CO (1) CO4990972A1 (da)
DE (1) DE69814441T2 (da)
DK (1) DK1027361T3 (da)
ES (1) ES2198766T3 (da)
HU (1) HUP0004323A2 (da)
IL (1) IL134996A0 (da)
NO (1) NO20002099L (da)
PL (1) PL340253A1 (da)
PT (1) PT1027361E (da)
SK (1) SK6342000A3 (da)
TR (1) TR200001140T2 (da)
TW (1) TW486485B (da)
WO (1) WO1999021864A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
WO2003095466A1 (en) * 2002-05-13 2003-11-20 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
NZ536402A (en) 2002-05-13 2006-08-31 Enanta Pharm Inc 6,11 bicyclic erythromycin derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT876388E (pt) * 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica

Also Published As

Publication number Publication date
EP1027361B1 (en) 2003-05-07
AR015986A1 (es) 2001-05-30
IL134996A0 (en) 2001-05-20
WO1999021864A1 (en) 1999-05-06
JP2001521038A (ja) 2001-11-06
CO4990972A1 (es) 2000-12-26
PT1027361E (pt) 2003-09-30
CA2307828A1 (en) 1999-05-06
BG104425A (bg) 2001-01-31
DE69814441T2 (de) 2004-04-08
TR200001140T2 (tr) 2001-05-21
TW486485B (en) 2002-05-11
BR9813317A (pt) 2000-08-22
NO20002099D0 (no) 2000-04-25
KR20010031591A (ko) 2001-04-16
ATE239750T1 (de) 2003-05-15
ES2198766T3 (es) 2004-02-01
DE69814441D1 (de) 2003-06-12
EP1027361A1 (en) 2000-08-16
NO20002099L (no) 2000-06-29
SK6342000A3 (en) 2000-09-12
AU1286799A (en) 1999-05-17
HUP0004323A2 (hu) 2001-02-28
PL340253A1 (en) 2001-01-29
CN1278266A (zh) 2000-12-27

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DE59501802D1 (de) Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ATE377018T1 (de) Erythromycinderivate
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
NO20003825L (no) 1,3,4 - oxadiazolonderivater
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
ATE234839T1 (de) 4,5-azolo-oxindole
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
PT1129079E (pt) Derivados de triazina 2,4-dissubstituidos
EP1156040A4 (en) 2,4-dioxo-5-ARYLIDENIMIDO-1,3-pyrimidines
ID26368A (id) Turunan-turunan 2 deoksi higromisin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.